GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 239 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q4 2019. The put-call ratio across all filers is 0.30 and the average weighting 0.3%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $108,029,000 | +1688.0% | 1,586,334 | +739.0% | 0.08% | +1825.0% |
| Q2 2022 | $6,042,000 | +281.7% | 189,084 | +313.7% | 0.00% | +300.0% |
| Q1 2022 | $1,583,000 | -67.6% | 45,703 | -72.7% | 0.00% | -66.7% |
| Q4 2021 | $4,893,000 | +111.5% | 167,128 | +84.0% | 0.00% | +200.0% |
| Q3 2021 | $2,314,000 | -42.3% | 90,825 | -20.7% | 0.00% | -50.0% |
| Q2 2021 | $4,013,000 | -0.7% | 114,587 | +15.5% | 0.00% | -33.3% |
| Q1 2021 | $4,041,000 | +74.5% | 99,169 | +85.4% | 0.00% | +200.0% |
| Q4 2020 | $2,316,000 | -7.2% | 53,475 | +18.2% | 0.00% | -50.0% |
| Q3 2020 | $2,495,000 | -61.5% | 45,253 | -55.9% | 0.00% | -60.0% |
| Q2 2020 | $6,482,000 | +40.9% | 102,677 | +14.0% | 0.01% | +25.0% |
| Q1 2020 | $4,599,000 | -51.9% | 90,031 | -25.1% | 0.00% | -42.9% |
| Q4 2019 | $9,559,000 | +105.3% | 120,248 | +25.3% | 0.01% | +133.3% |
| Q3 2019 | $4,656,000 | -9.7% | 95,953 | -2.1% | 0.00% | -25.0% |
| Q2 2019 | $5,157,000 | +122.2% | 98,052 | +123.6% | 0.00% | +33.3% |
| Q1 2019 | $2,321,000 | -77.0% | 43,853 | -82.2% | 0.00% | -70.0% |
| Q4 2018 | $10,099,000 | +319.2% | 246,035 | +288.2% | 0.01% | +400.0% |
| Q3 2018 | $2,409,000 | -48.5% | 63,373 | -38.8% | 0.00% | -50.0% |
| Q2 2018 | $4,680,000 | +122.6% | 103,544 | +138.0% | 0.00% | +300.0% |
| Q1 2018 | $2,102,000 | -35.4% | 43,505 | -47.4% | 0.00% | -50.0% |
| Q4 2017 | $3,252,000 | +66.3% | 82,671 | +31.3% | 0.00% | +100.0% |
| Q3 2017 | $1,956,000 | -18.6% | 62,957 | -28.3% | 0.00% | -50.0% |
| Q2 2017 | $2,402,000 | +205.6% | 87,819 | +311.5% | 0.00% | – |
| Q1 2017 | $786,000 | +255.7% | 21,339 | +40.1% | 0.00% | – |
| Q4 2016 | $221,000 | +497.3% | 15,226 | +827.3% | 0.00% | – |
| Q3 2016 | $37,000 | +42.3% | 1,642 | +5.9% | 0.00% | – |
| Q2 2016 | $26,000 | -71.1% | 1,550 | -72.6% | 0.00% | – |
| Q1 2016 | $90,000 | +32.4% | 5,654 | +167.6% | 0.00% | – |
| Q4 2015 | $68,000 | – | 2,113 | +105550.0% | 0.00% | – |
| Q3 2015 | $0 | – | 2 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alerce Investment Management, L.P. | 356,270 | $24,262,000 | 23.36% |
| Twin Securities, Inc. | 376,669 | $25,651,000 | 11.94% |
| Paradigm Biocapital Advisors LP | 1,175,879 | $80,077,000 | 10.68% |
| Chicago Capital Management, LLC | 246,246 | $16,769,000 | 9.12% |
| HARVEST MANAGEMENT LLC | 141,500 | $9,636,000 | 7.78% |
| Fernwood Investment Management, LLC | 174,724 | $11,899,000 | 5.02% |
| ArchPoint Investors | 168,725 | $11,490,000 | 4.69% |
| HAVENS ADVISORS LLC | 46,000 | $3,133,000 | 4.69% |
| Perceptive Advisors | 2,322,247 | $158,145,000 | 4.59% |
| Crabel Capital Management, LLC | 112,680 | $7,674,000 | 4.48% |